The ratio MDA/MDAa as a new index of platelet hyperactivity.
Since 1979, malonyldialdehyde (MDA) is considered a sensitive index of platelet hyperactivity. Stimulators of phospholipase A2 are used in the procedure of MDA production in order to obtain the final quantity (MDAa) which corresponds to the total amount of arachidonic acid present; without stimulation the production of MDA is minimal in non-activated platelets (MDA non-activated). Therefore, the more the MDA/MDAa ratio approaches unity, the more activated are the thrombocytes. We utilized for the first time this new index for the investigation of hyperactive platelets, and we studied 56 persons (17 patients with thrombophilic disease as group A, 17 normals as group B and 22 diabetics without ketoacidosis as group C). We proved that the new index (MDA/MDAa) can be used to detect persons with functionally hyperactive platelets because large differences are found between the mean values of normals and the values of patients with established thrombotic disease, at a high confidence limit (means +/- 3 SD covering 99% of the samples). Comparing the sensitivity of this new index with the other three methods used for the detection of hyperactive platelets [ratio of circulating platelet aggregates (CPA), aggregation with ADP, spontaneous aggregation] in groups B and C we found that only the ratio MDA/MDAa was able to reveal that (a) the two groups B and C are not identical (a statistical conclusion after comparison with the other methods) and (b) there were 5 diabetics in group C who had more hyperactive platelets than the others (these patients were not detected by any other method).
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000990:Antithrombin III / Q000378:metabolism; D001699:Biometry; D001792:Blood Platelets / Q000502:physiology*; D003920:Diabetes Mellitus / Q000097:blood; D006801:Humans; D066298:In Vitro Techniques; D008314:Malonates / Q000097:blood*; D008315:Malondialdehyde / Q000097:blood*; D010741:Phospholipases A / Q000097:blood; D054467:Phospholipases A2; D010974:Platelet Aggregation / Q000187:drug effects; D013927:Thrombosis / Q000097:blood
D008314:Malonates; D008315:Malondialdehyde; D000244:Adenosine Diphosphate; D000990:Antithrombin III; D010741:Phospholipases A; D054467:Phospholipases A2